Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder

Condition:   Female Sexual Arousal Disorder Interventions:   Drug: Sildenafil;   Drug: Placebo Sponsors:   Strategic Science & Technologies, LLC;   Daré Bioscience, Inc. Recruiting

Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials